Resident #5 arrived at Layhill Nursing and Rehabilitation Center needing the specialized medications that prevent his body from rejecting his transplanted heart. But staff failed to reconcile his medication orders during admission, missing the anti-rejection drugs entirely.
The oversight continued for weeks. A cardiologist ordered regular "trough" blood tests to monitor levels of the anti-rejection medications in the patient's system. Nursing staff dutifully collected blood samples and sent them to the laboratory.
Nobody questioned why they were testing for medications the resident wasn't getting.
The Director of Nursing acknowledged the dangerous gap when confronted by inspectors. She called it "another missed opportunity" and said the facility had implemented new processes to prevent similar incidents.
The medication error represents a breakdown at multiple levels of care. Anti-rejection drugs are essential for transplant patients - without them, the immune system attacks the new organ as foreign tissue. Regular blood monitoring ensures the medications remain at therapeutic levels.
But the monitoring is meaningless if the patient isn't receiving the drugs being measured.
Federal inspectors found the facility had recognized similar problems months earlier. An internal quality assurance report from May 1, 2025, identified a pattern of medication failures: staff weren't entering medication orders properly, medication reconciliation was breaking down, communication gaps existed between departments, and role responsibilities remained unclear.
The report also cited training deficiencies among nursing staff.
The facility's own analysis showed the problems had persisted from March 11 through May 5, 2025. During that period, multiple residents experienced medication errors due to the same systemic failures that later affected the heart transplant patient.
In response to the earlier problems, Layhill implemented mandatory training for charge nurses, enhanced admission protocols, and new supervisory follow-up processes. The facility also established pharmacist review procedures and continuous process evaluation.
Staff completed in-service education sessions, conducted audits of the admission process, administered quizzes to nursing personnel, and performed medication reconciliation audits by May 5.
Yet the heart transplant patient's case occurred months later, suggesting the corrective measures hadn't resolved the underlying issues.
The medication reconciliation process is designed to catch exactly these types of errors. When patients transfer between healthcare settings, staff must carefully compare the medications they were receiving at the previous facility with new orders from admitting physicians.
This cross-checking should have revealed that the cardiologist's monitoring orders didn't match the patient's actual medication regimen.
The case highlights how multiple safeguards can fail simultaneously. The admitting physician apparently prescribed different medications than the previous provider had ordered. The nursing staff didn't catch the discrepancy during admission. The pharmacist didn't flag the mismatch between monitoring orders and actual prescriptions.
Even the laboratory results should have raised questions - trough levels for medications not being administered would show zero or undetectable amounts.
The Director of Nursing's description of the incident as a "missed opportunity" understates the potential consequences for the heart transplant patient. Without anti-rejection medications, transplant recipients face the risk of organ rejection, which can be life-threatening.
The facility's history of medication errors compounds concerns about patient safety. The May quality assurance report documented systemic problems affecting multiple residents over nearly two months.
Those earlier failures involved the same core issues that led to the heart transplant patient's medication oversight: inadequate order entry, poor medication reconciliation, communication breakdowns, unclear responsibilities, and insufficient training.
The pattern suggests deeper organizational problems beyond individual staff mistakes.
Federal inspectors classified the violation as causing minimal harm or potential for actual harm to some residents. But for a heart transplant patient, missing anti-rejection medications represents a serious threat to survival.
The facility's repeated attempts at corrective action - first in May, then again after the transplant patient incident - indicate ongoing struggles to maintain basic medication safety protocols.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Layhill Nursing and Rehabilitation Center from 2025-10-09 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Layhill Nursing and Rehabilitation Center
- Browse all MD nursing home inspections